Combining Radiation + Immunotherapy
Combining Radiation + Immunotherapy This interview, “Combining Radiation +...
Read More
Talks by David Utz
Helping Patients Navigate the World of Clinical Trials
Helping Patients Navigate the World of Clinical Trials This interview, “Helping Patients...
Read More
Patients Speak Gerald Stern: Getting Chemo: My Story
Patients Speak Gerald Stern: Getting Chemo: My Story This interview, “Patients Speak Gerald...
Read More
Prostate Cancer Screening and Early Detection: Should We Follow the NCCN Guidelines? Con Argument
Robert E. Donohue, MD, argues against urologists adhering to the National Comprehensive Cancer Network (NCCN) Prostate Cancer Screening and Early Detection Guidelines. He proposes his own definitive answers to controversial questions relating to the use of digital rectal exams and PSA tests in baseline evaluation, indications for biopsy and biopsy technique, the age for initiation and discontinuation of testing, the frequency of testing, screening in high-risk populations, and which biomarkers to use.
Read More
Prostate Cancer Screening & Genetic Testing: The NCCN Perspective
J. Kellogg Parsons, MD, MHS, discusses the rationale behind the National Comprehensive Cancer Network (NCCN) guidelines on prostate cancer screening and how they fit in with currently available genetic testing. He describes the multi-disciplinary makeup of the NCCN, details considerations that led to their recommendations on when men should be screened and in which circumstances, and outlines opportunities to improve the guidelines through standardization, coordination with other organizations, and improved treatment algorithms.
Read More